Company news
Personalis, Inc. news in 2020
Personalis, Inc.'s news releases, calls and decks from 2020, newest first.
Personalis to Present at the 23rd Annual Needham Virtual Growth Conference
December 27, 2020
Personalis Announces the Launch of SHERPA™ for High-Accuracy Neoantigen Prediction and Cancer Diagnostic Biomarker Development
December 16, 2020
Personalis Announces the Launch of NEOPS™, a Neoantigen-based Composite Biomarker for Cancer Immunotherapy Response
December 16, 2020
Personalis Announces Delivery of the 100,000th Genome to the U.S. Department of Veterans Affairs Million Veteran Program
December 8, 2020
Personalis, Inc. to Present at EACR Liquid Biopsies Virtual Event
November 17, 2020
Personalis® to Present at the AMP Annual Meeting 2020
November 15, 2020
Personalis, Inc. to Present New Data at the Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting
November 8, 2020
Personalis Reports Third Quarter 2020 Financial Results
November 4, 2020
Personalis to Announce Third Quarter 2020 Financial Results on November 5, 2020
October 21, 2020
Personalis to Participate in Immuno Series US Virtual Meeting
October 14, 2020
Personalis, Inc. to Present at IO Combinations 360˚
September 30, 2020
Personalis to Participate in Digital World CB & CDx Meeting
September 28, 2020
Personalis Receives Contract Extension and New Task Order From the VA’s Million Veteran Program – Total Awarded to Date Now $175M
September 16, 2020
Personalis Strengthens Commercial Team with the Appointment of New Head of Population Genomics
September 14, 2020
Personalis to Participate at the Needham Virtual Cancer Diagnostics 1x1 Conference
August 11, 2020
Personalis Reports Second Quarter 2020 Financial Results
August 5, 2020
Personalis, Inc. Launches NeXT Liquid Biopsy™, A High-Performance, Exome-Wide Liquid Biopsy Platform
August 2, 2020
Personalis to Announce Second Quarter 2020 Financial Results on August 6, 2020
July 22, 2020
Personalis Further Expands Leadership Team With Appointment of Leslie Grab, VP of Intellectual Property and John Lyle, VP of Assay Research and Development
July 15, 2020
Personalis Completes Sequencing 75,000th Whole Human Genome for VA MVP
June 23, 2020
Personalis Announces New Data to be Presented at AACR Virtual Scientific Meeting
June 21, 2020
Personalis Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
June 15, 2020
Personalis Announces a Partnership with Berry Genomics for China Expansion
June 9, 2020
Personalis Announces Scientific Collaboration with Sarepta Therapeutics on Immune Response to Precision Genetic Therapeutics
June 1, 2020
Personalis, Inc. Announces New Data to be Presented at ASCO Virtual Scientific Meeting
May 28, 2020
Personalis Reports First Quarter 2020 Financial Results
May 6, 2020
Personalis, Inc. Appoints Industry Veteran Stephen Moore as General Counsel
May 4, 2020
Personalis Announces Renewed Clinical Laboratory Accreditation from College of American Pathologists
April 28, 2020
Personalis to Announce First Quarter 2020 Financial Results on May 7, 2020
April 22, 2020
Personalis, Inc. Expands Genomics Portfolio Across Disease Areas With Launch of Pharma Research Solutions for Use in Early Drug Discovery and Preclinical Studies
April 13, 2020
Personalis Reports Fourth Quarter and Full Year 2019 Financial Results
March 24, 2020
Personalis to Announce Fourth Quarter and Full Year 2019 Financial Results on March 25, 2020
March 10, 2020
Personalis, Inc. Announces the Launch of the NeXT Dx™ Test, a Comprehensive Genomic Cancer Profiling Test Enabling Advanced Composite Biomarkers for Cancer Treatment
January 6, 2020